Baptist Health Miami Cancer Institute expands partnership with COTA.
Miami Cancer Institute has recently utilized COTA’s analysis of RWE to change its testing policy for breast cancer gene mutations. With the new technology, the institute has decided to test every patient diagnosed with the condition. Not only will this help with early detection, but it will also allow for more personalized treatment plans.
